Health and Medicine

News about UB’s health sciences programs and related community outreach. (see all topics)

Meet an Expert
  • To Keep Social Drinkers Safe, One Tech Company Is Bringing Breathalyzers to the Bar
    11/7/11
    Buffalo Niagara and Canadian tech firm Ladybug Teknologies has launched a pilot program for the SipSmart Network, a breathalyzer kiosk that enables bar patrons to stay safe by checking their level of intoxication before they drive.
  • Anti-Bullying Center Offers Grounded Advice Amid the Outrage and Confusion
    11/7/11
    Although the passion and widespread sympathy for bullying victims is natural and admirable, those who want to stop bullying abuse need to act in ways that reflect good science and proven research if they want to contribute to a culture that does not condone this behavior, according to the director of the University at Buffalo's anti-bullying center. See video at http://www.youtube.com/watch?v=K5nUZOUbFHk
  • Exenatide (Byetta) Has Rapid, Powerful Anti-inflammatory Effect, UB Study Shows
    11/2/11
    Exenatide, a drug commonly prescribed to help patients with type 2 diabetes improve blood sugar control, also has a powerful and rapid anti-inflammatory effect, a University at Buffalo study has shown. The study of the drug, marketed under the trade name Byetta, was published recently in the Journal of Clinical Endocrinology and Metabolism.
  • UB Opens Alzheimer's Disease and Memory Disorders Center, a First for WNY
    10/31/11
    Families in Western New York and southern Ontario who are affected by Alzheimer's disease and related disorders now have a comprehensive new resource: the University at Buffalo's Alzheimer's Disease and Memory Disorders Center, the first in the region.
  • With Major New Grant, UB Is Training Physicians How to Best Treat Addicted Patients
    10/26/11
    A new University at Buffalo program, supported by more than $900,000 in federal funds, will help translate medical research on alcoholism and other addictions into the best treatments for addicted patients.
  • UB Researchers Investigate Ways to Reduce College Drinking and Risky Sex
    10/20/11
    In a recent study conducted by scientists at the University at Buffalo's Research Institute on Addictions involving 154 heavy-drinking college students whose sexual behavior put them at risk for HIV infection and other sexually transmitted diseases (STDs), there were two expected findings and one surprise.
  • Sexual Assault Scenarios -- and How To Prevent Them -- Will be Studied by UB Researcher
    10/13/11
    Kathleen A. Parks, senior research scientist at the University at Buffalo's Research Institute on Addictions, who studies women's substance use and associated victimization, recently received a grant from the National Institute on Alcohol Abuse and Alcoholism to continue her research on women's risks for sexual assault associated with heterosexual drinking situations.
  • New Method Isolates Best Brain Stem Cells to Treat MS
    10/13/11
    The prospect of doing human clinical trials with stem cells to treat diseases like multiple sclerosis may be growing closer, say scientists at the University at Buffalo and the University at Rochester, who have developed a more precise way to isolate stem cells that will make myelin.
  • New Drug Target for Alzheimer's, Stroke Is Discovered by UB Scientists
    10/11/11
    A tiny piece of a critical receptor that fuels the brain and without which sentient beings cannot live has been discovered by University at Buffalo scientists as a promising new drug target for Alzheimer's and other neurodegenerative diseases. The research on the NMDA (N-methyl-D-aspartate) receptor was published online Oct. 11 in Nature Communications.
  • 'Get Vaccinated,' Says HPV Expert at UB Medical School
    10/10/11
    A University at Buffalo microbiologist whose lab has been studying the human papilloma virus for years, says that parents should have their children vaccinated with Gardasil, the HPV vaccine.